ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARIA CARIAGA MD

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,993Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 1290

$764K Total Retail Price of All Prescriptions

Rank: 94 out of 1290

1,645 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 1,645 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,943 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
TRAMADOL HCL 1,032 644 1 25
VENTOLIN HFA 818 421 10 2 123
HYDROCODONE-ACETAMINOPHEN 633 316 S3 3 6
INSULIN SYRINGE 473 310 4 76
LANTUS 355 199 5 67
HUMULIN 70-30 340 236 6 240
ALENDRONATE SODIUM 301 247 7 39
ALLOPURINOL 294 205 8 60
LISINOPRIL 287 181 9 5
TEMAZEPAM 279 205 10 71
FLUTICASONE PROPIONATE 271 132 11 26
SIMVASTATIN 261 182 12 1
LEVOTHYROXINE SODIUM 246 143 13 4
NOVOLIN 70-30 221 131 14 233
METFORMIN HCL 217 141 15 10
ZOLPIDEM TARTRATE 213 127 16 15
GABAPENTIN 200 121 17 8
ACETAMINOPHEN-CODEINE 199 103 S3 18 138
ATORVASTATIN CALCIUM 198 128 19 23
OMEPRAZOLE 197 101 20 2
WARFARIN SODIUM 197 121 20 22
AMLODIPINE BESYLATE 189 129 22 3
DULERA 164 90 23 491
PROAIR HFA 157 72 24 73
FUROSEMIDE 145 90 25 9
LORAZEPAM 141 105 26 132
ADVAIR DISKUS 135 67 27 37
HYDRALAZINE HCL 134 104 28 133
RANITIDINE HCL 132 96 29 49
METHOTREXATE 125 82 30 56
PHENYTOIN SODIUM EXTENDED 123 45 31 203
GLIMEPIRIDE 122 82 32 57
HYDROCHLOROTHIAZIDE 104 64 33 20
SPIRONOLACTONE 101 56 34 126
LOSARTAN POTASSIUM 99 79 35 19
LEVEMIR 97 62 36 256
CARVEDILOL 96 60 37 12
METOPROLOL TARTRATE 95 53 38 7
CLOPIDOGREL 94 70 39 24
PRAVASTATIN SODIUM 91 56 40 42
PLAVIX 89 71 41 32
COMBIVENT 89 53 41 215
NOVOLIN N 88 61 43 411
LOVAZA 78 19 44 131
HUMULIN N 77 55 45 332
SERTRALINE HCL 75 20 46 36
METHIMAZOLE 71 50 47 232
NOVOLIN R 71 36 47 303
GALANTAMINE HBR 70 57 49 183
VIAGRA 69 36 50 124
CITALOPRAM HBR 69 50 50 29
ALPRAZOLAM 69 54 50 47
QVAR 68 40 53 370
AMIODARONE HCL 67 36 54 300
HUMULIN R 67 48 54 347
ATENOLOL 66 57 56 18
DOXAZOSIN MESYLATE 64 44 57 64
DILTIAZEM HCL 64 39 57 583
BENAZEPRIL HCL 61 44 59 140
LIPITOR 61 41 59 195
ACTOS 58 40 61 182
CLONIDINE HCL 58 39 61 66
BUPROPION HCL 57 0 63 379
TRAZODONE HCL 56 30 64 44
NAMENDA 54 52 65 27
MELOXICAM 54 38 65 31
VERAPAMIL ER 52 29 67 259
SOTALOL 50 50 68 226
POTASSIUM CHLORIDE 50 31 68 35
NAPROXEN 50 24 68 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.